valuat chang healthcar stock
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research feb
estim jan
price data feb
rate updat feb
currenc amount express
methodolog valu compani
make chang fair valu estim
within healthcar coverag result novel
outbreak scientist
physician grappl find treatment vaccin
investor eager find firm
promis technolog contain spread viru
help current infect patient recov exampl
share gilead rose significantli monday investor
process news first confirm case
appear respond gilead
placebo-control trial remdesivir begin
china potenti gener treatment option
also test make chang
gilead fair valu estim time beyond gilead
name coverag -- like roch whose diagnost arm
coronaviru assay avail research use
yet approv -- could see tailwind need
mask soap commod hospit suppli like
demand howev assum signific long-
term financi impact outbreak unless
stay power sale tend revers
follow year limit impact valuat
effect addit suppli use prevent
spread virus tend commodity-lik product
limit abil firm retain excess
profit especi long term
feb world organ confirm
case vast major case
diagnos china sever countri
report hand case jan declar
coronaviru outbreak global health emerg
public health emerg intern concern
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
johnson johnson world largest divers healthcar
compani three divis make firm pharmaceut medic devic
diagnost consum drug devic group repres close
sale drive major cash flow firm drug
divis focus follow therapeut area immunolog oncolog
neurolog pulmonari cardiolog metabol diseas devic
segment focus orthoped surgeri tool vision care
smaller area last segment consum focus babi care beauti
oral care over-the-count drug women health geograph
half total revenu gener unit state
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
biggest benefit potenti stockpil futur
outbreak although avail gener treatment
option malaria treatment chloroquin hiv booster
ritonavir seem inhibit viru accord scientist
wuhan institut virolog drug donat
make us cautiou assum multi-billion-dollar sale
similar roch tamiflu stockpil tamiflu
pandem stockpil sale peak chf billion
avian flu also hit chf billion swine flu
pheic signifi sever threat outsid china
within healthcar coverag think
biggest financi benefit could come firm
develop novel drug treat vaccin
prevent timelin regulatori approv
therapi highli uncertain vaccin even
manufactur quickli within month firm includ
smaller biotech like inovio pharma
firm like johnson johnson glaxo clinic trial would
like take month year safeti would
need verifi administ vaccin
healthi individu addit outbreak could
abat time vaccin deem safe prospect
treatment seem immedi promis
preliminari sign effect drug includ
proven effect relat coronaviru sar
effect anim model sar anoth
kaletra proteas inhibitor
recommend china nation health commiss
treatment although benefit
use could minim multipl gener firm
alreadi manufactur drug intern market
donat kaletra suppli china gilead
jan new england journal medicin publish
detail account treatment first confirm
 patient whose worsen condit
appar revers given nucleotid analog
remdesivir seventh day hospit earli last
week howev remdesivir enter clinic trial
wuhan hospit whether drug
could approv time treat signific number
patient outbreak uncertain assum
even approv month drug would like see
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
